These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34201730)

  • 41. Early Presymptomatic Changes in the Proteome of Mitochondria-Associated Membrane in the APP/PS1 Mouse Model of Alzheimer's Disease.
    Völgyi K; Badics K; Sialana FJ; Gulyássy P; Udvari EB; Kis V; Drahos L; Lubec G; Kékesi KA; Juhász G
    Mol Neurobiol; 2018 Oct; 55(10):7839-7857. PubMed ID: 29468564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapeutic Effects of Transplantation of As-MiR-937-Expressing Mesenchymal Stem Cells in Murine Model of Alzheimer's Disease.
    Liu Z; Wang C; Wang X; Xu S
    Cell Physiol Biochem; 2015; 37(1):321-30. PubMed ID: 26316079
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic perturbations of disease risk genes in mice capture transcriptomic signatures of late-onset Alzheimer's disease.
    Pandey RS; Graham L; Uyar A; Preuss C; Howell GR; Carter GW
    Mol Neurodegener; 2019 Dec; 14(1):50. PubMed ID: 31878951
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
    J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Age-related changes of brain iron load changes in the frontal cortex in APPswe/PS1ΔE9 transgenic mouse model of Alzheimer's disease.
    Xian-hui D; Wei-juan G; Tie-mei S; Hong-lin X; Jiang-tao B; Jing-yi Z; Xi-qing C
    J Trace Elem Med Biol; 2015 Apr; 30():118-23. PubMed ID: 25575693
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Trem2 R47H Alzheimer's risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans.
    Xiang X; Piers TM; Wefers B; Zhu K; Mallach A; Brunner B; Kleinberger G; Song W; Colonna M; Herms J; Wurst W; Pocock JM; Haass C
    Mol Neurodegener; 2018 Sep; 13(1):49. PubMed ID: 30185230
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of hypoxia on Alzheimer's disease-related APP and Tau mRNA formation.
    Jakubauskienė E; Vilys L; Pečiulienė I; Kanopka A
    Gene; 2021 Jan; 766():145146. PubMed ID: 32941952
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Full-length transcript sequencing of human and mouse cerebral cortex identifies widespread isoform diversity and alternative splicing.
    Leung SK; Jeffries AR; Castanho I; Jordan BT; Moore K; Davies JP; Dempster EL; Bray NJ; O'Neill P; Tseng E; Ahmed Z; Collier DA; Jeffery ED; Prabhakar S; Schalkwyk L; Jops C; Gandal MJ; Sheynkman GM; Hannon E; Mill J
    Cell Rep; 2021 Nov; 37(7):110022. PubMed ID: 34788620
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced protein isoform characterization through long-read proteogenomics.
    Miller RM; Jordan BT; Mehlferber MM; Jeffery ED; Chatzipantsiou C; Kaur S; Millikin RJ; Dai Y; Tiberi S; Castaldi PJ; Shortreed MR; Luckey CJ; Conesa A; Smith LM; Deslattes Mays A; Sheynkman GM
    Genome Biol; 2022 Mar; 23(1):69. PubMed ID: 35241129
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
    Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
    J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tau Exon 10 Inclusion by PrP
    Lidón L; Llaó-Hierro L; Nuvolone M; Aguzzi A; Ávila J; Ferrer I; Del Río JA; Gavín R
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065232
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Somatic APP gene recombination in Alzheimer's disease and normal neurons.
    Lee MH; Siddoway B; Kaeser GE; Segota I; Rivera R; Romanow WJ; Liu CS; Park C; Kennedy G; Long T; Chun J
    Nature; 2018 Nov; 563(7733):639-645. PubMed ID: 30464338
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
    Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
    J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
    Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
    PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of Circulating miR-125b as a Potential Biomarker of Alzheimer's Disease in APP/PS1 Transgenic Mouse.
    Hong H; Li Y; Su B
    J Alzheimers Dis; 2017; 59(4):1449-1458. PubMed ID: 28731435
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Pedrós I; Petrov D; Allgaier M; Sureda F; Barroso E; Beas-Zarate C; Auladell C; Pallàs M; Vázquez-Carrera M; Casadesús G; Folch J; Camins A
    Biochim Biophys Acta; 2014 Sep; 1842(9):1556-66. PubMed ID: 24887203
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transcript expression levels of full-length alpha-synuclein and its three alternatively spliced variants in Parkinson's disease brain regions and in a transgenic mouse model of alpha-synuclein overexpression.
    McLean JR; Hallett PJ; Cooper O; Stanley M; Isacson O
    Mol Cell Neurosci; 2012 Feb; 49(2):230-9. PubMed ID: 22155155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systematic analysis to identify transcriptome-wide dysregulation of Alzheimer's disease in genes and isoforms.
    Fan C; Chen K; Zhou J; Wong PP; He D; Huang Y; Wang X; Ling T; Yang Y; Zhao H
    Hum Genet; 2021 Apr; 140(4):609-623. PubMed ID: 33140241
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The hypothalamus as the primary brain region of metabolic abnormalities in APP/PS1 transgenic mouse model of Alzheimer's disease.
    Zheng H; Zhou Q; Du Y; Li C; Xu P; Lin L; Xiao J; Gao H
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):263-273. PubMed ID: 29107091
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential splicing of neuronal genes in a Trem2*R47H mouse model mimics alterations associated with Alzheimer's disease.
    Pandey RS; Kotredes KP; Sasner M; Howell GR; Carter GW
    BMC Genomics; 2023 Apr; 24(1):172. PubMed ID: 37016304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.